Baird Medical Charts 2025 Strategic Vision Following Milestone Year
On the first day, company leaders participated in the 7th
On the second day, Production Manager Le Zhang shared updates on product development progress and the 2025 production schedule, including plans to enhance after-sales service. Executives and managers discussed strategies to strengthen distributor relationships, ensuring alignment with Baird Medical's global expansion goals.
In 2024, Baird Medical's NASDAQ listing expanded its international recognition, positioning the company for further success in minimally invasive medical technologies. As the company enters 2025, Baird Medical remains committed to advancing in this field, confident in the team's ability to drive innovation, achieve growth, and successfully execute its strategic vision for the year ahead.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-charts-2025-strategic-vision-following-milestone-year-302326993.html
SOURCE BDMD
Eric Huang, PR Liaison, Baird Medical LLC, +1 (888) 508-6228, erichuang@bairdmed.com